Domenica Lorusso – Gynecological Oncologist – Best Researcher Award

Prof. Domenica Lorusso - Gynecological Oncologist - Best Researcher Award 

Humanitas University - Italy 

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Domenica Lorusso's academic journey began with excellence in the sciences at the State Scientific High School ‘G. Tarantino,’ Gravina in Puglia, where she graduated with top honors (60/60). She pursued a First Level Degree in Medicine and Surgery from the “Università Cattolica del Sacro Cuore” of Rome, achieving 110/110 cum laude in 1995. Furthering her specialization, she earned a Second Level Degree in Obstetrics and Gynecology in 1999, also with the highest distinction. These achievements laid the foundation for her remarkable career as a gynecological oncologist.

💼 Professional Endeavors

Prof. Lorusso’s illustrious career spans multiple prestigious institutions. Currently, she serves as the Head of the Gynecologic Oncology Unit at Humanitas San Pio X Hospital and as a Full Professor at Humanitas University. Her previous roles include Associate Professor at the “Università Cattolica del Sacro Cuore” and various leadership positions at “Fondazione Policlinico Universitario A Gemelli IRCCS” and “Fondazione IRCCS Istituto Nazionale Tumori.” Over the years, she has spearheaded initiatives in clinical research development and advanced medical therapies, showcasing her expertise as a gynecological oncologist.

🔬 Contributions and Research Focus

Prof. Lorusso has dedicated her career to advancing the diagnosis and treatment of gynecological neoplasms. She has led numerous clinical trials and contributed to innovative therapies in gynecologic oncology. Her research focus includes developing minimally invasive treatments, enhancing the effectiveness of clinical trials, and improving patient outcomes in oncological care. Her work as a gynecological oncologist has significantly shaped modern medical practices in this field.

🌍 Impact and Influence

The impact of Prof. Lorusso's contributions extends far beyond her immediate institutions. Her leadership in clinical research and medical therapy has influenced protocols and standards in gynecological oncology worldwide. Her collaboration with global institutions like MD Anderson Cancer Center and “San Giovanni” Hospital underscores her international reputation and expertise.

🏆Academic Cites

Prof. Lorusso’s research has been widely recognized, with her work being frequently cited in leading medical journals. Her innovative approaches to clinical trials and her contributions to gynecological oncology have established her as a trusted authority in the medical community.

🌟 Legacy and Future Contributions

Prof. Domenica Lorusso's legacy is defined by her unwavering commitment to excellence in gynecological oncology. She has played a crucial role in mentoring the next generation of medical professionals while continuing to contribute to groundbreaking research. Her vision for the future includes integrating advanced technologies into clinical practice, furthering innovation, and maintaining her role as a leader in gynecological oncology.

📝Gynecological Oncologist

Prof. Lorusso’s career exemplifies the pinnacle of achievement as a gynecological oncologist, with her research and clinical practice revolutionizing the field. Her role as a gynecological oncologist has had a profound impact on advancing medical therapies and improving patient care standards. The legacy of her contributions ensures that she will continue to inspire innovation and excellence in gynecological oncology.

Notable Publication


📝First-line Treatments for Advanced or Recurrent Endometrial Cancer: Systematic Literature Review of Clinical Evidence

Authors: Mirza, M.R., Lorusso, D., Shen, Q., Betts, M., Coleman, R.L.

Journal: Critical Reviews in Oncology/Hematology

Year: 2025

Citations: 0


📝Use of Individualized Starting Dose and Niraparib Hematologic Adverse Event Management Costs in Ovarian Cancer

Authors: Graybill, W.S., Vergote, I., Pothuri, B., Booth, D.V., González-Martín, A.

Journal: Journal of Comparative Effectiveness Research

Year: 2025

Citations: 0


📝Pembrolizumab Plus Chemotherapy for Advanced and Recurrent Cervical Cancer

Authors: Lorusso, D., Colombo, N., Dubot, C., Tewari, K.S., Monk, B.J.

Journal: Annals of Oncology

Year: 2025

Citations: 0


📝Clinical Ultrasound Algorithm to Identify Uterine Sarcoma and Smooth Muscle Tumors of Uncertain Malignant Potential

Authors: Ciccarone, F., Biscione, A., Robba, E., Scambia, G., Testa, A.C.

Journal: American Journal of Obstetrics and Gynecology

Year: 2025

Citations: 2


📝Safety and Tolerability of Mirvetuximab Soravtansine Monotherapy for Folate Receptor Alpha–Expressing Recurrent Ovarian Cancer

Authors: Moore, K.N., Lorusso, D., Oaknin, A., Birrer, M., Matulonis, U.A.

Journal: Gynecologic Oncology

Year: 2024

Citations: 0


📝Pembrolizumab for Locally Advanced Cervical Cancer – Authors' Reply

Authors: Lorusso, D., Yamada, K., Li, K., Cerrotta, A., Macchia, G.

Journal: The Lancet

Year: 2024

Citations: 0